LIN, Gloria Hoi Ying,VILLER, Natasja Nielsen,JOHNSON, Lisa Danae Schultz,WONG, Mark Michael,UGER, Robert Adam
申请号：
EP17781686
公开号：
EP3442593A4
申请日:
2017.04.13
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Blockade of the CD47/SIRPa pathway depletes cancer cells. This anti-cancer activity is enhanced when macrophage stimulating agents are used in combination with the CD47 blockade drug. This anti-cancer combination therapy is particularly effective when the CD47 blockade drug is SIRPaFc.
